calcium gluconate has been researched along with Encephalopathy, Toxic in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkins, CD | 1 |
| Hu, H; Liu, X; Lv, J; Sun, J; Wang, X; Xing, J | 1 |
| de Oliveira, GH; Machado, RG; Muzardo, GA | 1 |
| Dong, M; Feng, FY; Liu, P; Shi, YK; Xing, PY | 1 |
| Chay, WY; Choo, SP; Gao, F; Koo, WH; Lo, YL; Ng, HC; Ong, SY; Tan, SH | 1 |
| Alberts, SR; Chitaley, U; Dentchev, T; Grothey, A; Kugler, JW; Loprinzi, CL; Nikcevich, DA; Novotny, PJ; Silberstein, PT; Sloan, JA; Wender, DB | 1 |
| Chan, A; Chay, WY; Chiang, J; Lew, KY | 1 |
| Deoliveira, GH; Ehrich, M; Emerick, GL; Jortner, BS; Oliveira, RV | 1 |
| Ma, N; Piao, F; Yamauchi, T | 1 |
| Kowalski, T; Maier, C; Reinacher-Schick, A; Schlegel, U | 1 |
1 review(s) available for calcium gluconate and Encephalopathy, Toxic
| Article | Year |
|---|---|
[Painful hyperexcitability syndrome with oxaliplatin containing chemotherapy. Clinical features, pathophysiology and therapeutic options].
Topics: Adrenergic Uptake Inhibitors; Amifostine; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Calcium Carbonate; Calcium Gluconate; Colorectal Neoplasms; Cyclohexanols; Humans; Hyperalgesia; Magnesium Chloride; Nerve Fibers; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Peripheral Nerves; Rats; Selective Serotonin Reuptake Inhibitors; Sodium Channels; Venlafaxine Hydrochloride | 2008 |
3 trial(s) available for calcium gluconate and Encephalopathy, Toxic
| Article | Year |
|---|---|
[Assessment of the protective effect of calcium-magnesium infusion and glutathione on oxaliplatin-induced neurotoxicity].
Topics: Adolescent; Adult; Aged; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Calcium Gluconate; Colorectal Neoplasms; Double-Blind Method; Drug Therapy, Combination; Female; Fluorouracil; Glutathione; Humans; Infusions, Intravenous; Leucovorin; Magnesium Sulfate; Male; Middle Aged; Neurotoxicity Syndromes; Organoplatinum Compounds; Stomach Neoplasms; Young Adult | 2010 |
Use of calcium and magnesium infusions in prevention of oxaliplatin induced sensory neuropathy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcium Gluconate; Capecitabine; Cohort Studies; Colorectal Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Magnesium Sulfate; Male; Middle Aged; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Retrospective Studies; Treatment Outcome; Young Adult | 2010 |
Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Calcium Gluconate; Chemotherapy, Adjuvant; Chi-Square Distribution; Colonic Neoplasms; Double-Blind Method; Drug Combinations; Early Termination of Clinical Trials; Female; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Magnesium Sulfate; Male; Middle Aged; Neuroprotective Agents; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Sensation Disorders; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2011 |
6 other study(ies) available for calcium gluconate and Encephalopathy, Toxic
| Article | Year |
|---|---|
Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Calcium; Calcium Gluconate; Colonic Neoplasms; Female; Humans; Magnesium; Magnesium Sulfate; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Organoplatinum Compounds; Peripheral Nervous System Diseases; Sensation Disorders | 2014 |
The effect of hemoperfusion on patients with toxic encephalopathy induced by silkworm chrysalis ingestion.
Topics: Adult; Aged; Animals; Bombyx; Calcium Gluconate; Diuretics; Eating; Female; Fluid Therapy; Foodborne Diseases; Furosemide; Hemoperfusion; Humans; Male; Middle Aged; Neurotoxicity Syndromes; Omeprazole; Proton Pump Inhibitors; Pupa; Treatment Outcome | 2016 |
Effects of calcium gluconate and PMSF in the treatment of acute intoxication of chicken by TOCP.
Topics: Acute Disease; Animals; Calcium; Calcium Gluconate; Carboxylic Ester Hydrolases; Chickens; Neurotoxicity Syndromes; Phenylmethylsulfonyl Fluoride; Tritolyl Phosphates | 2008 |
Preventing oxaliplatin-induced sensory neurotoxicity: a methodology perspective.
Topics: Adenocarcinoma; Antineoplastic Agents; Calcium Gluconate; Clinical Trials as Topic; Colonic Neoplasms; Early Termination of Clinical Trials; Humans; Infusions, Intravenous; Magnesium Sulfate; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Research Design; Sensory Receptor Cells | 2011 |
Biochemical, histopathological and clinical evaluation of delayed effects caused by methamidophos isoforms and TOCP in hens: ameliorative effects using control of calcium homeostasis.
Topics: Acetylcholinesterase; Administration, Oral; Animals; Brain; Calcium; Calcium Gluconate; Calpain; Carboxylic Ester Hydrolases; Chickens; Female; Homeostasis; Insecticides; Neurotoxicity Syndromes; Nimodipine; Organothiophosphorus Compounds; Spinal Cord; Time Factors; Tritolyl Phosphates | 2012 |
The effect of Calcicol as calcium tonic on delayed neurotoxicity induced by organophosphorus compounds.
Topics: Animals; Behavior, Animal; Body Weight; Calcium; Calcium Gluconate; Chickens; Female; Gait Ataxia; Insecticides; Leptophos; Neurotoxicity Syndromes; Organophosphorus Compounds; Paralysis; Tritolyl Phosphates | 2003 |